( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
567.42
601.05
690.8
688.38
Total Expenditure
519.6
523.14
618.08
610.16
PBIDT (Excl OI)
47.81
77.91
72.71
78.22
Other Income
21.18
14.71
14.99
15.09
Operating Profit
69
92.62
87.70
93.31
Exceptional Items
-0.93
NA
1.4
NA
Depreciation
42.41
46.11
44.53
42.97
Profit Before Tax
21.94
42.13
41.10
46.72
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
16.21
31.52
30.29
33.19
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
16.21
31.52
30.29
33.19
Minority Interest
4.13
0.36
-1.69
-1.33
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
20.33
31.86
28.61
31.86
Equity Capital
1083.19
1083.19
1083.19
1083.19
Calculated EPS
0.01
0.02
0.02
0.02
Calculated EPS (Annualised)
0.07
0.11
0.10
0.11
No of Public Share Holdings
649338642
649338642
649338642
649338642
% of Public Share Holdings
59.95
59.95
59.95
59.95
PBIDTM% (Excl OI)
8.42
12.96
10.52
11.36
PBIDTM%
12.16
15.40
12.69
13.55
PBDTM%
11.34
14.68
12.39
13.02